{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:48:01Z","timestamp":1793785681168,"version":"4.6.1"},"reference-count":19,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,11,27]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Bacterial diversity was restored after FMT with oral frozen capsules, with improvement of diarrhea. Oral FMT for steroid-refractory acute gGVHD is feasible and could be effective.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018024968","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T11:45:48Z","timestamp":1542368748000},"page":"3097-3101","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":63,"title":["Fecal microbiota transplantation with frozen capsules for a patient with refractory acute gut graft-versus-host disease"],"prefix":"10.1182","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7966-291X","authenticated-orcid":false,"given":"Satoshi","family":"Kaito","sequence":"first","affiliation":[{"name":"Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7436-972X","authenticated-orcid":false,"given":"Takashi","family":"Toya","sequence":"additional","affiliation":[{"name":"Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Yoshifuji","sequence":"additional","affiliation":[{"name":"Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Kurosawa","sequence":"additional","affiliation":[{"name":"Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Inamoto","sequence":"additional","affiliation":[{"name":"Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozue","family":"Takeshita","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Suda","sequence":"additional","affiliation":[{"name":"Center for Integrative Medical Sciences, RIKEN, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5062-5795","authenticated-orcid":false,"given":"Kazuhiko","family":"Kakihana","sequence":"additional","affiliation":[{"name":"Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan; and"},{"name":"Center for Integrative Medical Sciences, RIKEN, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahira","family":"Hattori","sequence":"additional","affiliation":[{"name":"Center for Integrative Medical Sciences, RIKEN, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuteru","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,11,16]]},"reference":[{"issue":"9674","key":"2020021108401830400_B1","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"2020021108401830400_B2","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2141.2012.09114.x","article-title":"What predicts high risk acute graft-versus-host disease (GVHD) at onset?I Identification of those at highest risk by a novel acute GVHD risk score","volume":"157","author":"MacMillan","year":"2012","journal-title":"Br J Haematol"},{"issue":"7","key":"2020021108401830400_B3","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/bmt.2014.69","article-title":"Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation","volume":"49","author":"Castilla-Llorente","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2020021108401830400_B4","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.bbmt.2012.04.005","article-title":"First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation","volume":"18","author":"Martin","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2020021108401830400_B5","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1084\/jem.20112408","article-title":"Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation","volume":"209","author":"Jenq","year":"2012","journal-title":"J Exp Med"},{"issue":"5","key":"2020021108401830400_B6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bbmt.2014.01.030","article-title":"Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease","volume":"20","author":"Holler","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"16","key":"2020021108401830400_B7","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1182\/blood-2016-05-717652","article-title":"Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut","volume":"128","author":"Kakihana","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2020021108401830400_B8","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.3324\/haematol.2016.154351","article-title":"Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease","volume":"102","author":"Spindelboeck","year":"2017","journal-title":"Haematologica"},{"issue":"9","key":"2020021108401830400_B9","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1128\/AEM.67.9.4374-4376.2001","article-title":"Quantitative comparisons of 16S rRNA gene sequence libraries from environmental samples","volume":"67","author":"Singleton","year":"2001","journal-title":"Appl Environ Microbiol"},{"issue":"7","key":"2020021108401830400_B10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/cis580","article-title":"Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Taur","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2020021108401830400_B11","doi-asserted-by":"crossref","first-page":"ofv078","DOI":"10.1093\/ofid\/ofv078","article-title":"Loss of vancomycin-resistant enterococcus fecal dominance in an organ transplant patient with Clostridium difficile colitis after fecal microbiota transplant","volume":"2","author":"Stripling","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"2020021108401830400_B12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13054-015-0738-7","article-title":"Successful treatment of severe sepsis and diarrhea after vagotomy utilizing fecal microbiota transplantation: a case report","volume":"19","author":"Li","year":"2015","journal-title":"Crit Care"},{"issue":"17","key":"2020021108401830400_B13","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1001\/jama.2014.13875","article-title":"Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection","volume":"312","author":"Youngster","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"2020021108401830400_B14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12916-016-0680-9","article-title":"Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection","volume":"14","author":"Youngster","year":"2016","journal-title":"BMC Med"},{"issue":"20","key":"2020021108401830400_B15","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.2017.17077","article-title":"Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: a randomized clinical trial","volume":"318","author":"Kao","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"2020021108401830400_B16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/j.gastro.2016.11.010","article-title":"Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection","volume":"152","author":"Ott","year":"2017","journal-title":"Gastroenterology"},{"issue":"5","key":"2020021108401830400_B17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ajg.2011.482","article-title":"Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection","volume":"107","author":"Hamilton","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"2020021108401830400_B18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jama.2015.18098","article-title":"Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial","volume":"315","author":"Lee","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"2020021108401830400_B19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1182\/bloodadvances.2018017731","article-title":"Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity","volume":"2","author":"DeFilipp","year":"2018","journal-title":"Blood Adv"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/22\/3097\/1629968\/advances024968.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/22\/3097\/1629968\/advances024968.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T09:16:01Z","timestamp":1581412561000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/22\/3097\/16106\/Fecal-microbiota-transplantation-with-frozen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,16]]},"references-count":19,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2018,11,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018024968","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,16]]}}}